Macquarie Begins Coverage on Privia Health Group (NASDAQ:PRVA)

Macquarie started coverage on shares of Privia Health Group (NASDAQ:PRVA) in a research report report published on Monday, Marketbeat Ratings reports. The brokerage issued an outperform rating and a $25.00 target price on the stock.

Other equities analysts have also issued reports about the company. JPMorgan Chase & Co. lifted their price objective on Privia Health Group from $27.00 to $28.00 and gave the company an “overweight” rating in a research note on Friday, November 29th. Barclays increased their price objective on shares of Privia Health Group from $19.00 to $21.00 and gave the stock an “equal weight” rating in a research report on Friday, November 8th. Truist Financial raised their target price on shares of Privia Health Group from $24.00 to $27.00 and gave the company a “buy” rating in a research note on Friday, November 8th. Robert W. Baird upped their price target on shares of Privia Health Group from $23.00 to $24.00 and gave the stock an “outperform” rating in a research report on Monday, August 26th. Finally, KeyCorp assumed coverage on Privia Health Group in a research report on Friday, October 11th. They issued an “overweight” rating and a $23.00 price objective on the stock. Two analysts have rated the stock with a hold rating, twelve have issued a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Buy” and an average target price of $24.80.

Privia Health Group Stock Up 4.3 %

PRVA stock opened at $21.87 on Monday. The stock has a market capitalization of $2.62 billion, a price-to-earnings ratio of 218.72, a price-to-earnings-growth ratio of 5.45 and a beta of 0.83. The stock’s fifty day simple moving average is $20.05 and its 200-day simple moving average is $19.07. Privia Health Group has a 52-week low of $15.92 and a 52-week high of $24.30.

Institutional Investors Weigh In On Privia Health Group

A number of hedge funds have recently added to or reduced their stakes in PRVA. Millennium Management LLC grew its position in shares of Privia Health Group by 2,994.2% during the second quarter. Millennium Management LLC now owns 1,138,526 shares of the company’s stock worth $19,788,000 after acquiring an additional 1,101,730 shares during the last quarter. Eventide Asset Management LLC boosted its stake in Privia Health Group by 979.2% during the 3rd quarter. Eventide Asset Management LLC now owns 822,438 shares of the company’s stock valued at $14,977,000 after purchasing an additional 746,231 shares during the period. Icon Wealth Advisors LLC grew its position in Privia Health Group by 1,910.1% in the 3rd quarter. Icon Wealth Advisors LLC now owns 300,889 shares of the company’s stock worth $5,479,000 after purchasing an additional 285,920 shares during the last quarter. FMR LLC increased its stake in shares of Privia Health Group by 1.5% in the third quarter. FMR LLC now owns 18,169,043 shares of the company’s stock valued at $330,858,000 after purchasing an additional 271,645 shares during the period. Finally, BlackBarn Capital Partners LP raised its holdings in shares of Privia Health Group by 100.0% during the second quarter. BlackBarn Capital Partners LP now owns 400,000 shares of the company’s stock valued at $6,952,000 after buying an additional 200,000 shares during the last quarter. 94.48% of the stock is currently owned by institutional investors.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.